Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives
Tauroursodeoxycholic acid (TUDCA) is a naturally occurring hydrophilic bile acid that has been used for centuries in Chinese medicine. Chemically, TUDCA is a taurine conjugate of ursodeoxycholic acid (UDCA), which in contemporary pharmacology is approved by Food and Drug Administration (FDA) for tre...
| Published in: | Cells |
|---|---|
| Main Author: | Magdalena Kusaczuk |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2019-11-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/8/12/1471 |
Similar Items
Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice
by: Na Cui, et al.
Published: (2023-08-01)
by: Na Cui, et al.
Published: (2023-08-01)
Involvement of Endoplasmic Reticulum Stress in Uremic Cardiomyopathy: Protective Effects of Tauroursodeoxycholic Acid
by: Wei Ding, et al.
Published: (2016-01-01)
by: Wei Ding, et al.
Published: (2016-01-01)
Pharmacological and Metabolic Significance of Bile Acids in Retinal Diseases
by: Alice Win, et al.
Published: (2021-02-01)
by: Alice Win, et al.
Published: (2021-02-01)
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome
by: Lixing Feng, et al.
Published: (2021-12-01)
by: Lixing Feng, et al.
Published: (2021-12-01)
Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
by: Alejandra Daruich, et al.
Published: (2022-03-01)
by: Alejandra Daruich, et al.
Published: (2022-03-01)
Potential prophylactic effect of chemical chaperones for alleviation of endoplasmic reticulum stress in experimental diabetic cataract
by: Amany Abdel-Ghaffar, et al.
Published: (2019-04-01)
by: Amany Abdel-Ghaffar, et al.
Published: (2019-04-01)
The Bile Acid TUDCA Improves Beta-Cell Mass and Reduces Insulin Degradation in Mice With Early-Stage of Type-1 Diabetes
by: Gabriela Alves Bronczek, et al.
Published: (2019-05-01)
by: Gabriela Alves Bronczek, et al.
Published: (2019-05-01)
Large-scale production of tauroursodeoxycholic acid products through fermentation optimization of engineered Escherichia coli cell factory
by: Yingpeng Xu, et al.
Published: (2019-02-01)
by: Yingpeng Xu, et al.
Published: (2019-02-01)
Molecular and Cellular Effects of Chemical Chaperone—TUDCA on ER-Stressed NHAC-kn Human Articular Chondrocytes Cultured in Normoxic and Hypoxic Conditions
by: Magdalena Kusaczuk, et al.
Published: (2021-02-01)
by: Magdalena Kusaczuk, et al.
Published: (2021-02-01)
Natural Compounds from Saffron and Bear Bile Prevent Vision Loss and Retinal Degeneration
by: Laura Fernández-Sánchez, et al.
Published: (2015-07-01)
by: Laura Fernández-Sánchez, et al.
Published: (2015-07-01)
Tauroursodeoxycholic acid: a bile acid that may be used for the prevention and treatment of Alzheimer’s disease
by: Honghu Song, et al.
Published: (2024-02-01)
by: Honghu Song, et al.
Published: (2024-02-01)
Inhibition of Endoplasmic Reticulum Stress Improves Acetylcholine-Mediated Relaxation in the Aorta of Type-2 Diabetic Rats
by: Sagir Mustapha, et al.
Published: (2022-08-01)
by: Sagir Mustapha, et al.
Published: (2022-08-01)
Long-term benefits of TUDCA supplement in ARSACS zebrafish model
by: Valentina Naef, et al.
Published: (2025-07-01)
by: Valentina Naef, et al.
Published: (2025-07-01)
Effects of oral tauroursodeoxycholic acid and/or intestinal probiotics on serum biochemical indexes and bile composition in patients with cholecystolithiasis
by: Fan Gao, et al.
Published: (2022-10-01)
by: Fan Gao, et al.
Published: (2022-10-01)
Pre-treatment with IL-6 potentiates β-cell death induced by pro-inflammatory cytokines
by: V. R. Oliveira, et al.
Published: (2023-03-01)
by: V. R. Oliveira, et al.
Published: (2023-03-01)
Insights by which TUDCA is a potential therapy against adiposity
by: Israelle Netto Freitas, et al.
Published: (2023-02-01)
by: Israelle Netto Freitas, et al.
Published: (2023-02-01)
Bile Acids and Liver Cancer: Molecular Mechanism and Therapeutic Prospects
by: Xuemei Zhang, et al.
Published: (2024-08-01)
by: Xuemei Zhang, et al.
Published: (2024-08-01)
Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases
by: Kareem Khalaf, et al.
Published: (2022-06-01)
by: Kareem Khalaf, et al.
Published: (2022-06-01)
Bile Acids in Cholestasis and its Treatment
by: Juan Pablo Arab, et al.
Published: (2017-11-01)
by: Juan Pablo Arab, et al.
Published: (2017-11-01)
TUDCA combined with Syndopa protects the midbrain and gut from MPTP toxicity in a Parkinson’s disease mouse model: Immunohistochemical evidence
by: Mahalakshmi Rajan, et al.
Published: (2025-08-01)
by: Mahalakshmi Rajan, et al.
Published: (2025-08-01)
Multifaceted Interactions Between Bile Acids, Their Receptors, and MASH: From Molecular Mechanisms to Clinical Therapeutics
by: Xuan Tang, et al.
Published: (2025-07-01)
by: Xuan Tang, et al.
Published: (2025-07-01)
Tauroursodeoxycholic Acid Protects Retinal Ganglion Cells and Reduces Inflammation in Mice Following Optic Nerve Crush
by: Nan Zhang, et al.
Published: (2025-04-01)
by: Nan Zhang, et al.
Published: (2025-04-01)
The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells
by: Magdalena Kusaczuk, et al.
Published: (2024-08-01)
by: Magdalena Kusaczuk, et al.
Published: (2024-08-01)
A Recent Ten-Year Perspective: Bile Acid Metabolism and Signaling
by: Yulia Shulpekova, et al.
Published: (2022-03-01)
by: Yulia Shulpekova, et al.
Published: (2022-03-01)
Targeting the regulatory mechanisms that determine tissue damage and repair
by: Frank Wagener, et al.
Published: (2016-08-01)
by: Frank Wagener, et al.
Published: (2016-08-01)
Bile Acid Physiology
by: Agostino Di Ciaula, et al.
Published: (2017-11-01)
by: Agostino Di Ciaula, et al.
Published: (2017-11-01)
The secondary bile acids, ursodeoxycholic acid and lithocholic acid, protect against intestinal inflammation by inhibition of epithelial apoptosis
by: Natalia K. Lajczak‐McGinley, et al.
Published: (2020-06-01)
by: Natalia K. Lajczak‐McGinley, et al.
Published: (2020-06-01)
Transcriptome and physiological analyses for revealing genes involved in wheat response to endoplasmic reticulum stress
by: Xing Yu, et al.
Published: (2019-05-01)
by: Xing Yu, et al.
Published: (2019-05-01)
Evaluation of Resting Serum Bile Acid Concentrations in Dogs with Sepsis
by: Lara Baptista, et al.
Published: (2022-11-01)
by: Lara Baptista, et al.
Published: (2022-11-01)
Fisetin limits Chikungunya virus-induced apoptosis hallmarks in hepatocellular carcinoma cells
by: Rafidah Lani, et al.
Published: (2025-07-01)
by: Rafidah Lani, et al.
Published: (2025-07-01)
VSV infection and LPS treatment alter serum bile acid profiles, bile acid biosynthesis, and bile acid receptors in mice
by: Yamei Li, et al.
Published: (2024-11-01)
by: Yamei Li, et al.
Published: (2024-11-01)
Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
by: Alberto Albanese, et al.
Published: (2022-09-01)
by: Alberto Albanese, et al.
Published: (2022-09-01)
Inhibition of Bile Acid Accumulation Decreased the Excessive Hepatocyte Apoptosis and Improved the Liver Secretion Functions on Obstructive Jaundice Patients
by: Toar J. M. Lalisang, et al.
Published: (2011-08-01)
by: Toar J. M. Lalisang, et al.
Published: (2011-08-01)
Prostaglandins - universal biological regulators in the human body (literature review)
by: О. V. Tymoshchuk, et al.
Published: (2018-02-01)
by: О. V. Tymoshchuk, et al.
Published: (2018-02-01)
The Time-Course of Antioxidant Irisin Activity: Role of the Nrf2/HO-1/HMGB1 Axis
by: Agnieszka Irena Mazur-Bialy, et al.
Published: (2021-01-01)
by: Agnieszka Irena Mazur-Bialy, et al.
Published: (2021-01-01)
Profiling bile acid composition in bile from mice of different ages and sexes
by: Jiajian Liu, et al.
Published: (2025-09-01)
by: Jiajian Liu, et al.
Published: (2025-09-01)
Bile-Acid-Appended Triazolyl Aryl Ketones: Design, Synthesis, In Vitro Anticancer Activity and Pharmacokinetics in Rats
by: Devesh S. Agarwal, et al.
Published: (2021-09-01)
by: Devesh S. Agarwal, et al.
Published: (2021-09-01)
Correlations of bile acids in the bile of rats in conditions of alloxan induced diabetes melitus
by: N. N. Danchenko, et al.
Published: (2014-12-01)
by: N. N. Danchenko, et al.
Published: (2014-12-01)
Chlorogenic acid attenuates liver apoptosis and inflammation in endoplasmic reticulum stress-induced mice
by: Azam Moslehi, et al.
Published: (2023-04-01)
by: Azam Moslehi, et al.
Published: (2023-04-01)
Anti-apoptotic signaling as a cytoprotective mechanism in mammalian hibernation
by: Andrew N. Rouble, et al.
Published: (2013-02-01)
by: Andrew N. Rouble, et al.
Published: (2013-02-01)
Similar Items
-
Metabolomics and Lipidomics Study Unveils the Impact of Tauroursodeoxycholic Acid on Hyperlipidemic Mice
by: Na Cui, et al.
Published: (2023-08-01) -
Involvement of Endoplasmic Reticulum Stress in Uremic Cardiomyopathy: Protective Effects of Tauroursodeoxycholic Acid
by: Wei Ding, et al.
Published: (2016-01-01) -
Pharmacological and Metabolic Significance of Bile Acids in Retinal Diseases
by: Alice Win, et al.
Published: (2021-02-01) -
Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome
by: Lixing Feng, et al.
Published: (2021-12-01) -
Comparative Analysis of Urso- and Tauroursodeoxycholic Acid Neuroprotective Effects on Retinal Degeneration Models
by: Alejandra Daruich, et al.
Published: (2022-03-01)
